B cell therapy with the anti‐CD22 monoclonal antibody epratuzumab: Comment on the editorial by St.Clair and Tedder
Year: 2006
Type: letter
Source: Arthritis & Rheumatism
DOI: 10.1002/art.21937
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1975629018
